Overview
Teva Pharmaceutical Industries, headquartered in Tel Aviv, develops, produces and sells medicines, and reports by geography: United States, Europe and International Markets.[2] In the United States it sells a central-nervous-system portfolio and distributes generic, biosimilar and over-the-counter products to pharmacies, hospitals and physicians.[2] Forbes records sales of US$17.4bn, up 5.2%, and profit of US$1.6bn.[2] Teva is the largest generic-medicines company in this ranking; Viatris, ranked twenty-second, and Sandoz, which is outside the top 25, both have smaller sales.[2] It is the only Israeli company in the top 25 and keeps eighteenth position. Forbes gives its founding year as 1901 and counts 33,346 employees.[2]
Teva Pharmaceutical strengths and limitations
Strengths
- Largest generics company in the ranking
- Returned to profit from a prior-year loss of US$1.6bn
- Broad geographic reach
Limitations
- Generic pricing pressure
- Profit margin under 10%
- Smaller specialty portfolio than branded peers
Appears in
Teva Pharmaceutical peers and competitors
Companies ranked in the same lists as Teva Pharmaceutical.
Johnson & Johnson- Amgen
Daiichi Sankyo- Astellas Pharma
Viatris- Regeneron Pharmaceuticals
- CSL
Otsuka Holdings
Merck KGaA
Gilead Sciences
Takeda Pharmaceutical
GSK plc
Is this your company?
Update the description, logo, image and link through the submission form. Editors review every change.